Related Experiment Videos
New modality of collapse therapy for pulmonary tuberculosis sequels: tissue expander
François Bertin1, Louis Labrousse, Virgile Gazaille
1Department of Thoracic and Cardiovascular Surgery and Angiology, Centre Hospitalier Universitaire Limoges, Limoges, France. francois.bertin@chu-limoges.fr
The Annals of Thoracic Surgery
|August 28, 2007
Summary
This study introduces percutaneous tissue expanders as a novel collapse therapy for tuberculosis cavities, potentially avoiding complications like foreign body migration seen with traditional methods.
Area of Science:
- Pulmonology
- Thoracic Surgery
- Infectious Diseases
Background:
- Classical collapse therapy for tuberculosis sequelae, using extrapleural Lucite balls, presents risks of long-term complications, notably foreign body migration.
- Residual tuberculous cavities pose challenges in treatment and management.
Observation:
- A new approach utilizing percutaneous tissue expanders for collapse therapy in tuberculosis cavitation was investigated.
- This method aims to mitigate the complications associated with traditional foreign body placement.
Findings:
- The use of percutaneous tissue expanders resulted in an uneventful postoperative course.
- Mid-term follow-up demonstrated functional improvement and no recurrence of tuberculosis infection.
Implications:
- This novel collapse therapy offers a potentially safer alternative for managing post-tuberculosis residual cavities.
- It may reduce long-term complications, including foreign body migration, and minimize physical and physiological sequelae.
Related Concept Videos
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pneumothorax II: Pathophysiology
Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
Flail Chest-II
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History: